Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
Sugar increases your risk of endometrial cancer (EC) while curcumin and green tea extract reduce your risk of endometrial cancer. Let’s break it down…
There are a growing number of studies that indicate that sugar intake increases risks for certain cancers. The studies below discuss endometrial cancer and its link to sugar. It should also be noted that reducing sugar intake post-therapy may be an effective therapy to remain in remission.
And while I encourage endometrial cancer (EC) survivors to moderate their diet I also encourage EC patients and survivors to supplement those evidence-based, non-toxic therapies that research has shown can reduce your risk of a first EC diagnosis as well as a relapse of EC.
I am both a cancer survivor and cancer coach. Research and experience have taught me that there are many evidence-based, non-toxic therapies to reduce the risk of EC such as curcumin and green tea extract (see below).
Please scroll down the page, post a question or comment and I will reply to you ASAP.
“Postmenopausal women who reported the highest intake of sugar-sweetened beverages had a 78 percent increased risk for estrogen-dependent type I EC (the most common type of this disease). This association was found in a dose-dependent manner: the more sugar-sweetened beverages a woman drank, the higher her risk…
“Research has documented the contribution of sugar-sweetened beverages to the obesity epidemic,” said Inoue-Choi. “Too much added sugar can boost a person’s overall calorie intake and may increase the risk of health conditions such as obesity, diabetes, heart disease, and cancer.”
“In conclusion, curcumin inhibits tumor cell migration and invasion by reducing the expression and activity of MMP-2/9 via the suppression of the ERK signaling pathway, suggesting that curcumin is a potential therapeutic agent for EC…”